This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Risk of fatal ICH without alteplase for stroke
{ "resourceType": "Evidence", "id": "example-stroke-no-alteplase-fatalICH", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p>\n "Risk of fatal ICH without alteplase for stroke" is a univariate risk estimate.\n </p>\n\t</div>" }, "url": "http://hl7.org/fhir/Evidence/example-stroke-no-alteplase-fatalICH", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113883.4.642.10.4" } ], "title": "Risk of fatal ICH without alteplase for stroke", "status": "draft", "relatedArtifact": [ { "type": "citation", "label": "Emberson 2014", "display": "Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.", "citation": "Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063", "document": { "url": "https://doi.org/10.1016/S0140-6736(14)60584-5" } } ], "description": "0.4% incidence of fatal intracranial hemorrhage within 7 days without alteplase in patients with acute ischemic stroke", "variableDefinition": [ { "variableRole": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/variable-role", "code": "population", "display": "population" } ] }, "observed": { "reference": "Group/AcuteIschemicStroke", "type": "Group", "display": "adults with acute ischemic stroke" }, "intended": { "reference": "Group/AcuteIschemicStroke", "type": "Group", "display": "adults with acute ischemic stroke" } }, { "variableRole": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/variable-role", "code": "population", "display": "population" } ] }, "observed": { "reference": "Group/Emberson-2014-IPD-MA-No-Alteplase-Cohort", "type": "Group", "display": "Emberson 2014 IPD-MA No Alteplase Cohort" }, "intended": { "reference": "Group/AcuteIschemicStrokeTreatedWithoutAlteplase", "type": "Group", "display": "adults with acute ischemic stroke treated without alteplase" } }, { "variableRole": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/variable-role", "code": "measuredVariable", "display": "measured variable" } ] }, "observed": { "reference": "EvidenceVariable/example-fatal-ICH-in-7-days", "type": "EvidenceVariable", "display": "fatal ICH" }, "intended": { "reference": "EvidenceVariable/example-fatal-ICH-in-7-days", "type": "EvidenceVariable", "display": "fatal ICH" } } ], "synthesisType": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/synthesis-type", "code": "IPD-MA", "display": "individual patient data meta-analysis" } ] }, "studyDesign": [ { "coding": [ { "system": "http://hl7.org/fhir/research-study-classifiers", "code": "SEVCO:01003", "display": "randomized assignment" } ] } ], "statistic": [ { "statisticType": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/statistic-type", "code": "C44256", "display": "Proportion" } ] }, "quantity": { "value": 0.00386298627 }, "numberOfEvents": 13, "sampleSize": { "numberOfStudies": 9, "numberOfParticipants": 3365 } } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.